Abstract
Many studies have shown a relationship between fragmented nocturnal sleep and daytime sleepiness. In the current study, 9 patients, aged 55-79, with fragmented nocturnal sleep secondary to periodic leg movements and objective daytime sleepiness, as verified by Multiple Sleep Latency Test (MSLT), had 12 weeks of treatment with 0.125 mg of triazolam following 2 screening nights and 2 placebo baseline nights; 2 final placebo nights were placed 5 nights following the last medication night. The medication increased total sleep time and sleep efficiency throughout the administration period, as compared to average placebo values; total leg movements were not changed. Generally, daytime performance, as measured by a vigilance task, and objective alertness, as measured by MSLT, were improved following the use of triazolam. No adverse reactions or significant side effects were noted. It was concluded that 0.125 mg triazolam, when used for up to 3 months, could improve sleep and daytime function in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness. (Aging 3: 321-332, 1991)
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Carskadon M.A., Van den Hoed J., Dement W.C.: Insomnia and sleep disturbances in the aged. J. Geriatr. Psychiatr. 13: 135–151, 1980.
Carskadon M.A., Brown E.D., Dement W.C.: Sleep fragmentation in the elderly: relationship to daytime sleep tendency. Neurobiol. Aging 3: 321–327, 1982.
Montplaisir J., Godbout R.: Restless legs syndrome and periodic movements during sleep. In: Kryger M.H., Roth T., Dement W.C. (Eds.), Principles and Practice of Sleep Medicine. W.B. Saunders, Philadelphia, 1989, pp. 402–409.
Bonnet M.H.: The recovery of performance during sleep following sleep deprivation in older normal and insomniac adult males. Percept. Mot. Skills 60: 323–334, 1985.
Bonnet M.H.: Performance and sleepiness as a function of frequency and placement of sleep disruption. Psychophysiology 23: 263–271, 1986.
Coleman R.M., Roffwarg H.P., Kennedy S.J., Guilleminault C., Cinque J., Cohn M.A., Karacan I., Kupfer D.J., Lemmi H., Miles L.E., Orr W.C., Phillips E.R., Roth T., Sassin J.F., Schmidt H.S., Weitzman E.D., Dement W.C: Prevalence of sleep-wake disorders based on a polysomnographic diagnosis. JAMA 247: 997–1003, 1982.
Guilleminault C., Raynal D., Weitzman E.D., Dement W.C: Sleep-related periodic myoclonus in patients complaining of insomnia. Trans. Am. Neurol. Assoc. 100: 19–21, 1975.
Guilleminault C., Flagg W.: Effect of baclofen on sleep-related periodic leg movements. Ann. Neurol. 15: 234–239, 1984.
Mitler M.M., Browman C.P., Menn S.J., Krishnareddy G., Timms R.M.: Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep 9: 385- 392, 1986.
Montplaisir J., Godbout R., Boghen D., DeChamplain J., Young S.N., Lapierre G., Ing M.: Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study. Neurology 35: 130–134,1985.
Oshtory M., Vijayan N.: Clonazepam treatment of insomnia due to sleep myoclonus. Arch. Neurol. 37: 119–120, 1980.
Ohanna N., Peled R., Rubin A.H.E, Zomer J., Lavie P.: Periodic leg movements in sleep: effect of clonazepam treatment. Neurology 35: 408–410, 1985.
Rosenthal L., Roehrs T., Sicklesteel J., Zorick F., Wittig R., Roth T.: Periodic movements during sleep, sleep fragmentation, and sleep-wake complaints. Sleep 7: 326–330, 1984.
Saskin P., Moldofsky H., Lue F.: Periodic movements in sleep and sleep-wake complaint. Sleep 8: 319–324, 1985.
Bonnet M.H., Arand D.L.: The use of triazolam in older patients with periodic leg movements, fragmented sleep and daytime sleepiness. J. Gerontol. 45: M139–M144; 1990.
Roehrs T., Zorick F., Wittig R., Roth T.: Efficacy of a reduced triazolam dose in elderly insomniacs. Neurobiol. Aging 6: 293–296, 1985.
Roehrs T., Zorick F., Wittig R., Roth T.: Dose determinants of rebound insomnia. Br. J. Clin. Pharmacol. 22: 143–147, 1986.
Coleman R.M.: Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C (Ed.), Sleeping and Waking Disorders Indications and Techniques. Addison-Wesley, Menlo Park, 1982, pp. 265–296.
Bonnet M.H., Kramer M., Rosa R.R.: The hypnotic effectiveness of ketazolam in anxious subjects. Curr. Ther. Res. 28: 284–293, 1980.
Mitler M., Seidel W., Van den Hoed J., Greenblatt D., Dement W.C: Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study. J. Clin. Psy- chopharmacol. 4: 2–13, 1983.
Bornstein S.K.: Respiratory monitoring during sleep: polysomnography. In: Guilleminault C. (Ed.), Sleeping and Waking Disorders Indications and Techniques. Addison-Wesley, Menlo Park, 1982, pp. 183–212.
Rechtschaffen A., Kales A.: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Brain Information Service/ Brain Research Institute, University of California at Los Angeles, Los Angeles, 1968.
Carskadon M.A., Dement W.D.: The multiple sleep latency test: What does it measure? Sleep 5: S67–S72, 1982.
Wilkinson R.T.: Sleep deprivation: Performance tests for partial and selective sleep deprivation. In: Abt L.E., Reiss B.F. (Eds.), Progress in Clinical Psychology, vol. 8. Grune & Stratton, New York, 1968, pp. 28–43.
Scerbo M.W., Warm J.S., Fisk A.D.: Event asynchrony and signal regularity in sustained attention. Curr. Psychol Res. Rev. 5: 335–343, 1987.
Williams H.L., Geisking C., Lubin A.: Some effects of sleep loss on memory. Percept. Mot. Skills 23: 1287–1293, 1966.
Lubin A., Moses J.M., Johnson L.C., Naitoh P.: The recuperative effects of REM sleep and stage 4 sleep on human performance after complete sleep loss: experiment 1. Psychophysiology 11: 133–146, 1974.
Leibowitz M., Sunshine A.: Long-term hypnotic efficacy and safety of triazolam and flurazepam. J. Clin. Pharmacol. 18: 302–309, 1978.
Carskadon M.A., Scidel W., Greenblatt D., Dement W.: Daytime carryover of triazolam and fluorazepam in elderly insomniacs. Sleep 5: 361–371, 1982.
Moldofsky H., Tullis C., Quance G., Lue F.A.: Nitrazepam for periodic movements in sleep (sleep-related myoclonus). Can. J. Neurol. Sci. 13: 52–54, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonnet, M.H., Arand, D.L. Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness. Aging Clin Exp Res 3, 313–324 (1991). https://doi.org/10.1007/BF03324027
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324027